A functional role for small-conductance calcium-activated potassium channels in sensory pathways including nociceptive processes

J Neurosci. 2005 Apr 6;25(14):3489-98. doi: 10.1523/JNEUROSCI.0597-05.2005.

Abstract

We investigated the role of small-conductance calcium-activated potassium (SK) and intermediate-conductance calcium-activated potassium channels in modulating sensory transmission from peripheral afferents into the rat spinal cord. Subunit-specific antibodies reveal high levels of SK3 immunoreactivity in laminas I, II, and III of the spinal cord. Among dorsal root ganglion neurons, both peripherin-positive (C-type) and peripherin-negative (A-type) cells show intense SK3 immunoreactivity. Furthermore, dorsal root-stimulated sensory responses recorded in vitro are inhibited when SK channel activity is increased with 1-ethyl-2-benzimidazolinone (1-EBIO). In vivo electrophysiological recordings show that neuronal responses to naturally evoked nociceptive and nonnociceptive stimuli increase after application of the selective SK channel blocker 8,14-diaza-1,7(1,4)-diquinolinacyclotetradecaphanedium di-trifluoroacetate (UCL 1848), indicating that SK channels are normally active in moderating afferent input. Conversely, neuronal responses evoked by mechanical stimuli are inhibited when SK channel activity is increased with 1-EBIO. These effects are reversed by the subsequent application of UCL 1848. Our data demonstrate that SK channels have an important role in controlling sensory input into the spinal cord.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Benzimidazoles / pharmacology
  • Calcium Channel Agonists / pharmacology
  • Cell Line
  • Dose-Response Relationship, Drug
  • Electric Stimulation / methods
  • Ependyma / metabolism
  • Female
  • Ganglia, Spinal / cytology
  • Humans
  • Immunohistochemistry / methods
  • In Vitro Techniques
  • Intermediate Filament Proteins / metabolism
  • Male
  • Membrane Glycoproteins / metabolism
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Membrane Potentials / radiation effects
  • Nerve Fibers / drug effects
  • Nerve Fibers / physiology
  • Nerve Tissue Proteins / metabolism
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / physiology*
  • Pain / physiopathology*
  • Patch-Clamp Techniques / methods
  • Peripherins
  • Physical Stimulation / methods
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Calcium-Activated / drug effects
  • Potassium Channels, Calcium-Activated / physiology*
  • Quinolinium Compounds / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Reaction Time / drug effects
  • Reaction Time / physiology
  • Spinal Cord / cytology*
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Synaptic Transmission / radiation effects
  • TRPV Cation Channels / metabolism
  • Time Factors
  • Transfection

Substances

  • 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane
  • Benzimidazoles
  • Calcium Channel Agonists
  • Intermediate Filament Proteins
  • Membrane Glycoproteins
  • Nerve Tissue Proteins
  • PRPH protein, human
  • Peripherins
  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated
  • Quinolinium Compounds
  • TRPV Cation Channels
  • TRPV1 receptor
  • 1-ethyl-2-benzimidazolinone